Building healthier communities
TBVI seeks socially responsible companies and responsible business leaders to engage with us in building healthier communities, where citizens, employees and their families are free from tuberculosis. Companies supporting our solutions to eliminate TB will make an effective social investment into global communities with remarkable positive impacts.
|
Developing cost-effective vaccines is crucial in the fight against tuberculosis. The disease affects millions of people and economies worldwide, whether in Europe, Africa or Asia. Drug resistance and co-infection with HIV threaten populations and businesses around the globe.
Companies can support us with financial resources, expertise, know-how, in kind gifts, support in clinical trials, raising awareness for the health, social and economic impact of tuberculosis or other leverage. To discuss all opportunities for these invaluable partnerships, please contact us.
As part of our strategy, our working model and our projects, TBVI commits to responsible use of all resources, effective solutions and long term positive social and economic impact.
What do we offer our partners?
- Access to our research results
- Possibilities for participation in Council of Trustees of TBVI, our prestigious network of globally renowned scientists, academic and political experts in health
- Working together on development of tools against elimination of TB
- Participation in our innovative way of funding, combining investment and charity
- Possibilities for tax incentives
- Cross sector cooperation – foundations, governments and private industries in a strong partnership to eliminate a major global health issue
- Pan-European approach – joint expertise of almost 40 worldwide research expert institutions
- For sponsors we offer access to the latest developments by our research partners in so-called interface meetings.
Social Impact
- With new vaccines save around 2 million lives a year and prevent suffering for millions of people
- Bring concrete solutions - TBVI's track record already shows high probability of success. Vaccines generally proved as promising and cost efficient
- Reduce poverty and stigmatization of people affected by tuberculosis
- Relieve communities affected by tuberculosis from the social and economic burdens caused by the disease
- Long term impact
- Healthy communities for people and businesses
Economic impact
- New vaccines will save hundreds of billions euro to the world economy, as the economic loss caused by tuberculosis now amounts to 0,52 per cent of the world’s gross national income
- Contribution to Europe's new knowledge based economy and technology
- Direct benefits to society: economic and social return on investment
- Cost efficiency: no investment wasted
- Knowledge and experience that is transferable worldwide
- Leverage – elimination of tuberculosis will economically benefit families, communities, governments and companies.
Contact
Danielle Roordink
Advocacy & Resource Mobilization Officer / Project Manager
+31 320 277 554
danielle.roordink(at)tbvi.eu
TBVI represents opportunities to get into a large network of experts
Kalevi Reijonen, CEO FIT Biotech

